MedTrace Logo

Carbetocin Versus Oxytocin and Hemodynamic Effects

NCT00977769 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2014-05-06

Study results available
· View outcomes & findings →

Summary

A randomized double-blind trial of oxytocin 5 u, carbetocin 100 µg and placebo with hemodynamic response as a primary outcome measure.

Conditions

  • Effects of; Anesthesia, in Pregnancy

Interventions

DRUG

carbetocin 100 µg

Hemodynamic effect of

DRUG

oxytocin 5 u

Hemodynamic effect of

DRUG

placebo (NaCl)

Hemodynamic effect of

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Leiv Arne Rosseland, MD PhD · Oslo University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2011-08-31
Completion
2011-10-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00977769 on ClinicalTrials.gov